Bioxytran, Inc
BIXT· OTC
Filed Nov 14, 2011 · 10-Q · 45 days after period end · 0001213900-11-005945
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $13.20K | $1.79K |
| Net Income | -$346.04K | -$71.39K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 14, 2011 · 45 d after period end